Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Completes Shareholder-Allocated Paid-in Capital Increase Payment… Final Issue Amount Confirmed at KRW 2.92T

Posted on July 9, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Completes Shareholder-Allocated Paid-in Capital Increase Payment… Final Issue Amount Confirmed at KRW 2.92T

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-07-09

Disclosure Type: Result of Paid-in Capital Increase or Issuance of Equity-Related Bonds (Voluntary Disclosure)

💡 3-Second Summary

Hanwha Aerospace has officially finalized its fundraising process by completing the full payment for its shareholder-allocated paid-in capital increase of 4,267,200 common shares, securing a total of KRW 2,918,764,800,000 on July 9, 2025.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Type of Securities: Registered common shares
  • Method of Issuance: Shareholder-allocated paid-in capital increase (Public offering of forfeited shares after shareholder allocation)
  • Issuance Volume and Value:
    • Expected Shares to Issued: 4,267,200 shares ➔ Actual Shares Issued: 4,267,200 shares (No change)
    • Expected Issue Amount: KRW 2,918,764,800,000 ➔ Actual Issue Amount: KRW 2,918,764,800,000 (No change)
  • Key Administrative Timeline:
    • Initial Board Resolution Date for Issuance: March 20, 2025 (Subsequent resolutions on April 8, 2025, and April 30, 2025)
    • Payment Date (Final Execution): July 9, 2025
    • Scheduled Listing Date for New Shares: July 21, 2025

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This disclosure serves as a regulatory notification confirming the definitive administrative closure of the payment window for the shareholder-allocated paid-in capital increase initiated via the initial board resolution on March 20, 2025. It certifies that the actual number of shares and the total funding value have been successfully deposited as planned, establishing the final procurement of KRW 2.92T without any structural deviations from the initial targets.

From a numerical standpoint, the primary parameter for investors to verify is the designated new share listing date set for July 21, 2025. The text of the disclosure focuses entirely on the completion of the transaction and does not encompass broken-down capital utilization plans, descriptions of expenditure destinations, or qualitative impacts on diluted earnings per share. The filing provides no analytical commentary regarding stock price trajectories or subsequent trading supply factors; therefore, investors may treat the official listing date schedule and the parameters logged in preceding related entries (such as the initial decision and securities registration statements) as the primary metrics for objective confirmation.

📝 Editor’s Comment (by K-STOCK Editor)

This voluntary filing delivers only the factual confirmation that the payment process for the shareholder-allocated paid-in capital increase has been officially executed as of July 9, 2025. The core text focuses entirely on administrative metrics—including the finalized share counts, the total procured capital value, and the upcoming new share registration date—omitting forecasting regarding subsequent corporate structure changes or secondary market adjustments.

The primary variable for investors to verify moving forward is the execution of the listing schedule set for July 21, 2025. Because this filing functions solely to verify the definitive finalization of the cash inflow phase, investors may focus on tracking the designated timeline and cross-referencing future periodic financial statements to reconcile the expansion of total outstanding shares against these verified quantitative indices objectively.

📢 Disclaimer & Source Information

Source: This content has been structured and newly generated based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Samsung Biologics(207940) Confirms Schedule for H1 2025 Earnings Release
Next Post: [Disclosure] SK Hynix (000660) to Host Q2 2025 Earnings Conference Call on July 24 with Live Simultaneous Webcast

Related Posts

[Disclosure] Samsung Electronics (005930) Finalizes Q3 2024 Operating Profit at 9.18T KRW; Jumps 277% YoY but Drops 12% QoQ Amid Structural Transitions Semiconductors
[Disclosure] Celltrion (068270), Secures FDA Phase 3 Clinical Trial Application Approval for CT-P13 SC (Zymfentra) in Rheumatoid Arthritis Patients Disclosures
[Disclosure] SK Hynix (000660) – Decides FY2025 Year-End Cash Dividend (KRW 1,875 per Common Share, Totaling KRW 1.32T) Semiconductors
[Disclosure] Alteogen (196170) Signs Exclusive License Agreement with AstraZeneca Subsidiary for ALT-B4 Valued up to USD 600M (KRW 872.9B) Disclosures
[Disclosure] Alteogen(196170) Designated as ‘Investment Warning Stock’; Takes Effect from February 28 Disclosures
[Disclosure] Hanwha Ocean (042660) Secures KRW 378.4B Contract with Oceanian Shipowner for 2 VLCCs Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme